Clinical trial
Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid…
NCT00007878 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00007878 |
|---|---|
| Title | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery |
| Official title | A Phase I Study of PS-341 in Combination With 5-FU/LV in Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | bortezomib, fluorouracil, leucovorin calcium, pharmacological study, laboratory biomarker analysis |
| Enrollment | 30 |
| Start date | Sep 1, 2000 |
| Primary completion | Jan 1, 2008 |
| First posted | Feb 16, 2004 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: